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Abstract
We present the case of an 8 year-old girl in a developing country with significant corneal scarring
and multiple cutaneous skin lesions in sun-exposed areas. Neuro-developmental delay had been
present since 3 months of age, and taken as a whole the consensus was that this clinical picture was
consistent with Xeroderma Pigmentosum (XP). We highlight the difficulties encountered due to
the lack of diagnostic and treatment modalities for this child, and offer a brief review of XP,
including emerging treatments that show potential.
Case report
We present the case of an 8 year-old girl who presented to
the out-patient department of a small hospital in Santiago
Atitlàn, Guatemala, after maternal concern regarding pro-
gressive ocular lesions. The family was of Mayan heritage
and spoke Tz'utujil and a small amount of Spanish. The
history was unusual: since the age of 3 months the patient
had suffered with persistent developmental delay as well
as the appearance of multiple pigmented papular lesions
on her face, neck, and forearms. Over time these lesions
had enlarged and become progressively more numerous
and raised, although were confined to sun-exposed areas.
In the last year her mother had noted gradually enlarging
corneal lesions bilaterally.
Following normal vaginal delivery at home with no pre-
natal care, development had been limited to social smil-
ing, sufficient fine motor skills to feed herself, infrequent
speech of only single words, and an unsteady gait.
Although a generally happy and smiling child, the patient
had never been self-caring with regard to dressing and toi-
leting, and was still wearing nappies.
She had 2 normal siblings, and there was no family his-
tory or other past medical history of note. The mother
denied any consanguinity in the patient's recent lineage.
On examination the patient was smiling and playful, and
appeared well-nourished. Large hyperkeratotic lesions
were present on the cheeks and nose with some indura-
tion suspicious of actinic keratosis and early squamous
cell carcinoma. There were also numerous hyper-pig-
mented lentigos and xerosis limited to sun-exposed sites.
Marked corneal scarring was evident bilaterally (Figures 1,
2, 3). There was no evidence of anaemia or overt signs of
vitamin deficiencies such as rickets, and the mother and
siblings appeared well nourished.
Physical examination of the heart, lungs and abdomen
was unremarkable. There was mild choreoathetosis of the
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right arm, and gait was broad-based and grossly ataxic.
Eye movements exhibited rolling nystagmus, but were
able to track large objects. The patient was constantly
reaching to the ground, trying to pick up things and put
them in her mouth – either a neuro-developmental prob-
lem, or possibly indicative of pica. Unfortunately no lab-
oratory testing was available for further investigation.
Given the cutaneous, neurological and ocular features a
presumptive diagnosis of Xeroderma Pigmentosum was
made. As facilities for pathological diagnosis were not
available an opinion was sought from international col-
leagues. There was consensus that the clinical features
were those of a photosensitive dermatoses with Xero-
derma Pigmentosum being the most likely given the strik-
ing cutaneous features.
The patient was offered referral to ophthalmology and
paediatric specialists in Guatemala City, which was
declined. The patient has subsequently been lost to follow
up.
Discussion
Xeroderma Pigmentosum (XP) is a rare genetic disorder
that occurs worldwide in all races and ethnic groups. First
described by Hebra and Kaposi in 1874 the disorder is
characterised by marked photosensitivity and premature
onset of all major types of skin cancer [1].
From an early age patients are sensitive to even minimal
sun exposure developing erythema, vesicles and oedema.
By the age of two years solar lentigos, xerosis and pigmen-
tation occur. Later in childhood dysplastic and neoplastic
Frontal image of face, showing large hyperkeratotic lesions  with some induration suspicious of actinic keratosis and early  squamous cell carcinoma Figure 1
Frontal image of face, showing large hyperkeratotic 
lesions with some induration suspicious of actinic 
keratosis and early squamous cell carcinoma. Also 
numerous hyper-pigmented lentigos and xerosis on the 
entire front of the face. Marked corneal scarring and injec-
tion is evident.
Close-up of the face shows the corneal scarring and ulcera- tion, as well as the diffuse hyperkeratotic lesions Figure 2
Close-up of the face shows the corneal scarring and 
ulceration, as well as the diffuse hyperkeratotic 
lesions.
This left lateral view of the face shows the diffuse nature of  the hyperpigmented lentigos on the face and neck, as well as  demonstrating again the corneal damage and para-nasal  hyperkeratosis Figure 3
This left lateral view of the face shows the diffuse 
nature of the hyperpigmented lentigos on the face 
and neck, as well as demonstrating again the corneal 
damage and para-nasal hyperkeratosis.Cases Journal 2008, 1:254 http://www.casesjournal.com/content/1/1/254
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lesions occur with the development of actinic keratosis,
keratocanthoma, basal cell carcinoma, squamous cell car-
cinoma and malignant melanoma [1]. In one study the
median age for development of malignant melanoma was
8 years of age [2]. Ocular complications are nearly as com-
mon as skin lesions with keratitis progressing to corneal
opacification, loss of eyelashes, ectropion, entropion and
benign and malignant lesions of the cornea and eyelids.
Neurological complications occur in approximately 30%
of cases and can be severe [1,3].
XP is usually inherited in an autosomal recessive manner
with phenotypically normal heterozygotes. There are at
least seven different subtypes (complementation groups
A-G) as well as XP variants. Various rare forms occur in
combination with other disorders such as Cockayne's Syn-
drome [1]. 80% of patients have classical XP where there
is a defect in the initiation of DNA nucleotide excision
repair after UV induced damage. In XP variant the defect
is found in post-replication or daughter-strand repair.
The diagnosis of XP is considered when a young patient
presents with marked photosensitivity, xerosis and multi-
ple pigmented lesions. Phototesting may be performed
showing reduced minimal erythema dose in the 290 to
340 nm range [4]. Although phototesting is widely avail-
able in the developed world it is neither sensitive or spe-
cific for XP. The diagnostic test of choice is time
consuming, highly specialised and expensive: cultured
fibroblasts are extracted from a skin biopsy, fused with
fibroblasts from known XP lines and exposed to UV irra-
diation. If the subsequent DNA repair is defective, the XP
complementation group may be identified from the fused
XP line used. Recent developments include the cloning of
all XP genes, so the complementation group can also be
determined by using recombinant retroviral vectors.
Guatemala has no centralized health records for preva-
lence of XP or subtype analysis, and to date there has been
only one published report of a cluster of cases of the group
C complementation form in a single rural Guatemalan
community [5]. Of the sub-types, XP-V occurs at a later
age and is less debilitating, while XP-C and XP-E sufferers
do not usually have neurological complications. XP-A or
XP-D are the most likely genotypes to have caused the
phenotypic presentation of this patients.
Management of XP consists of early and rigorous photo-
protection with sun avoidance, sunscreens and appropri-
ate clothing. Experimental treatments with topical DNA
repair enzymes and oral retinoids are showing promise
for the future [6,7].
There are particular challenges when a child with XP
grows up in a tropical environment as illustrated by this
case. The geographical and cultural bars to medical facili-
ties led to a significant delay in diagnosis for this patient.
This has resulted in years of photodamage resulting in the
patients striking appearance and undoubted limited
lifespan. Culturally the patient would have spent most of
the day outdoors in the equatorial high UV exposure envi-
ronment. Even if a medical opinion was sought earlier in
life we must consider the lack of local specialists and the
high cost of the specialised diagnostic tests needed. Per-
haps most importantly the language barrier limited the
medical team's ability to perform genetic counselling vital
to the parents and local tribes understanding of the condi-
tion.
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